Analyst Price Targets — EOLS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 4, 2026 12:32 pm | Uy Ear | Mizuho Securities | $15.00 | $4.70 | TheFly | Evolus price target lowered to $15 from $19 at Mizuho |
| January 22, 2026 12:15 pm | — | BTIG | $13.00 | $4.90 | TheFly | Evolus price target lowered to $13 from $18 at BTIG |
| January 13, 2026 12:12 pm | Annabel Samimy | Stifel Nicolaus | $17.00 | $5.77 | TheFly | Evolus price target lowered to $17 from $20 at Stifel |
| December 1, 2025 9:34 pm | Vamil Divan | Mizuho Securities | $19.00 | $6.82 | StreetInsider | Evolus (EOLS) PT Lowered to $19 at Mizuho |
| October 3, 2024 6:57 am | Douglas Tsao | H.C. Wainwright | $27.00 | $17.05 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Evolus (EOLS) |
| September 13, 2024 5:26 am | Balaji Prasad | Barclays | $20.00 | $16.46 | TheFly | Evolus price target raised to $20 from $16 at Barclays |
| September 13, 2024 5:11 am | Vamil Divan | Mizuho Securities | $25.00 | $16.46 | StreetInsider | Evolus (EOLS) PT Raised to $25 at Mizuho |
| January 29, 2024 3:32 am | Balaji Prasad | Barclays | $16.00 | $13.47 | StreetInsider | Barclays Upgrades Evolus (EOLS) to Overweight |
Latest News for EOLS
BlackRock Inc. acquired a new stake in shares of Evolus, Inc. (NASDAQ: EOLS) during the second quarter, according to its most recent disclosure with the SEC. The fund acquired 4,840,828 shares of the company's stock, valued at approximately $33,595,000. BlackRock Inc. owned approximately 7.35% of Evolus as of its most recent SEC filing.
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture P
The mean of analysts' price targets for Evolus (EOLS) points to a 77.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Evolus, Inc. (NASDAQ: EOLS - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $8.82 and last traded at $8.78, with a volume of 1320192 shares. The stock had previously closed at $8.39. Wall Street Analysts Forecast Growth EOLS has been the subject
Assenagon Asset Management S.A. lifted its holdings in Evolus, Inc. (NASDAQ: EOLS) by 51.8% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 908,180 shares of the company's stock after acquiring an additional 310,035 shares during the period. Assenagon Asset
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EOLS.
U.S. House Trading
No House trades found for EOLS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.